Resources and insights to help you keep up with policy and market trends in a transforming healthcare ecosystem

Showing Articles

Natalie Reid, Manager at ADVI, served as the analyst for an article in the Journal of General Internal Medicine

Natalie Reid, Manager at ADVI, served as the analyst for the recently published article in the Journal of General Internal Medicine, “Patterns of Hospital Performance on the Hospital-Wide 30-Day Readmission Metric: Is the Playing Field Level?” that suggests the hospital-wide readmission (HWR) metrics should be reassessed as a quality measure. The paper found that the hospital-level characteristics of academic status (AAMC), AAMC plus National Cancer Institute, safety net status, and over 400 beds were associated with the performing more poorly in the HWR metric.

Read more

A conversation with Mike Kolodziej MD and Marc Samuels

Mike Kolodziej discusses his career history, leadership, and the changing trends of healthcare.

Read more

Government negotiation of prescription drug prices isn’t a panacea for lower costs

With Republican plans for health care reform stalled, and scrutiny surrounding prescription drug costs intensifying, a White House in desperate need of a policy victory may soon sharpen its focus on drug pricing. Since working with Congress on health care is proving to be difficult, President Trump may decide to do it via the executive branch.

Read more

BCBS ‘Evidence Street’ Group Enabling Engagement
With MDx Players

ADVI Chief Clinical Officer Louis Jacques MD was recently interviewed by GenomeWeb, a highly regarded outlet for news in the molecular diagnostic test arena, about the planned collaboration of BCBSA Evidence Street and the Palmetto GBA Medicare MolDX program. Jacques noted that Medicare has used external technology assessments to inform some of its national coverage policy decisions, so the paradigm is not inconsistent with CMS precedents. He reassured readers that MolDX would be expected use the publicly transparent current Local Coverage Determination process, and that Evidence Street would not be writing Medicare coverage policies.

Read more